Roche Holding AG (DELISTED) (RHHVF:DL)
432.80
+29.91
(+7.42%)
USD |
OTCM |
Mar 17, 16:03
Roche Price : 432.80 for March 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 16, 2026 | 409.64 | 422.39 | 400.00 | 402.89 | 3010.00 |
| Mar 13, 2026 | 423.51 | 424.48 | 400.00 | 418.84 | 56796.00 |
| Mar 12, 2026 | 428.14 | 434.53 | 402.11 | 430.00 | 422.00 |
| Mar 11, 2026 | 391.95 | 456.62 | 391.71 | 426.72 | 2420.00 |
| Mar 10, 2026 | 426.97 | 447.45 | 425.09 | 438.21 | 37966.00 |
| Mar 09, 2026 | 424.00 | 437.99 | 414.86 | 437.99 | 457.00 |
| Mar 06, 2026 | 448.56 | 455.49 | 427.74 | 439.07 | 33510.00 |
| Mar 05, 2026 | 471.77 | 471.77 | 433.37 | 449.03 | 87761.00 |
| Mar 04, 2026 | 456.47 | 471.00 | 455.77 | 464.19 | 38327.00 |
| Mar 03, 2026 | 456.00 | 467.49 | 445.25 | 452.25 | 769.00 |
| Mar 02, 2026 | 476.50 | 478.36 | 460.00 | 470.60 | 375254.0 |
| Feb 27, 2026 | 480.00 | 485.00 | 465.98 | 480.00 | 500.00 |
| Feb 26, 2026 | 473.00 | 480.00 | 462.62 | 480.00 | 25282.00 |
| Feb 25, 2026 | 470.91 | 485.37 | 470.91 | 473.06 | 1212.00 |
| Feb 24, 2026 | 486.09 | 488.88 | 477.78 | 482.56 | 25146.00 |
| Feb 23, 2026 | 475.00 | 482.00 | 468.99 | 480.00 | 729.00 |
| Feb 20, 2026 | 463.59 | 481.90 | 458.88 | 480.00 | 1006.00 |
| Feb 19, 2026 | 488.88 | 488.88 | 465.99 | 477.44 | 39336.00 |
| Feb 18, 2026 | 470.76 | 486.00 | 470.76 | 478.88 | 52709.00 |
| Feb 17, 2026 | 490.33 | 490.33 | 469.42 | 487.10 | 12870.00 |
| Feb 13, 2026 | 459.96 | 480.22 | 457.58 | 478.66 | 26094.00 |
| Feb 12, 2026 | 460.00 | 470.00 | 460.00 | 466.28 | 21954.00 |
| Feb 11, 2026 | 473.23 | 473.23 | 453.46 | 466.69 | 61765.00 |
| Feb 10, 2026 | 464.07 | 468.00 | 452.85 | 465.01 | 109593.0 |
| Feb 09, 2026 | 463.02 | 464.90 | 454.48 | 454.48 | 27659.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Galderma Group AG | 41.51 |
| EvoNext Holdings SA | 1.10 |
| Kuros Biosciences Ltd. | 26.00 |
| Basilea Pharmaceutica AG | 60.28 |
Price Related Metrics
| PE Ratio | 22.52 |
| PS Ratio | 4.689 |
| PEG Ratio | 1.063 |
| Price to Free Cash Flow | 23.06 |
| Earnings Yield | 4.44% |
| Market Cap | 344.34B |
| PEGY Ratio | 0.9273 |
| Operating PE Ratio | 15.26 |
| Normalized PE Ratio | 19.31 |